Gene Discovery News: Breaking Gene Discovery News, Comments and Articles. - Page: 5

12:24 EST 26th November 2014 | BioPortfolio

Gene Discovery News - Page: 5RSS

Read the latest Gene Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Gene Discovery.

Search or Follow Our Gene Discovery - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Gene Discovery - Page: 5 News.

Showing "gene discovery" News Articles 101 to 125 of 7,600+

Tuesday 25th November 2014

Juno Appoints Maggie Wilderotter To Board Of Directors

SEATTLE, Nov. 25, 2014 /PRNewswire-USNewswire/ -- Juno Therapeutics today announced that Maggie Wilderotter, Chairman and CEO of Frontier Communications Corporation, has been appointed to the Juno Board of Directors.  Wilderotter, the eighth member of Juno's Board of Directors, brings significant public company experience as both a board member and a senior executive to the Juno Board...

Gene discovered that reduces risk of stroke

A gene that protects people against one of the major causes of stroke in young and middle-aged adults has been discovered, and researchers say that it could hold the key to new treatments.

Try Some Reactions. Actually, Try Them All.

Here's a really nice example of high-throughput reaction discovery/condition scouting from a team at Merck. They certainly state the problem correctly: Modern organic synthesis and especially transition metal catalysis is redefining the rules with w...

Parent Project Muscular Dystrophy and Santhera Pharmaceuticals Team Up on Benefit/Risk Study in Duchenne

HACKENSACK, N.J., Nov. 25, 2014 /PRNewswire-USNewswire/ -- Parent Project Muscular Dystrophy (PPMD), the leading advocacy organization working to end Duchenne muscular dystrophy (Duchenne) and  Santhera Pharmaceuticals (SIX: SANN), a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neu...

Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Children With Spinal Muscular Atrophy

CARLSBAD, Calif., Nov. 25, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today the initiation of a pivotal Phase 3 study evaluating ISIS-SMNRx in approximately 120 non-ambulatory children with spinal muscular atrophy (SMA).  SMA is a severe and rare genetic neuromuscular disease characterized by muscle atrophy and weakness.  The Phase 3 study, CHERISH, is the s...

Genetic test unlocks cause of Brisbane boy's rare disease

Queensland researchers have led an international effort to uncover the gene behind a young Brisbane boy's rare developmental condition, in a discovery his family hopes will pave the way for future treatments.

Apitope Receives Orphan Designation in the European Union for ATX-F8-117 for the Treatment of Haemophilia A

DIEPENBEEK, Belgium, November 25, 2014 /PRNewswire/ -- Treatment for haemophilia A patients developing Factor VIII inhibitors   Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has granted ...

Janssen touts Transposagen technology in CAR-T collaboration

Janssen sees a lot of potential for Transposagen's genome-editing technologies in the development of chimeric antigen receptor T-cell (CAR-T) treatments and other gene or cell therapies. Transposagen's platforms could be used to develop off-the-shelf...

BioLife Solutions to Present at the LD Micro "Main Event" Investor Conference on Wednesday, December 3, 2014

BOTHELL, Wash., Nov. 25, 2014 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"), today announced that it will be presenting at the LD MICRO "Main Event" Micro-Cap G...

Dotmatics' ELN, Inventory and Chemical Registration Platform Implemented by Euroscreen

BISHOP'S STORTFORD, England, November 25, 2014 /PRNewswire/ -- Dotmatics' Platform to power Euroscreen's chemistry database   Dotmatics, a leading provider of scientific informatics solutions and services, announced today the implementation of the Dotmatics Platform at Euroscreen, a privately owned preclinical-stage, drug discovery and development company in Belgium. Euroscreen has upd...

$1 Billion Oncology Alliance between Menarini Group & Oxford BioTherapeutics Initiates First-in-Human Study of Enhanced Antibody for Treatment of Acute Myeloid Leukemia

OXFORD, England and BERLIN, November 25, 2014 /PRNewswire/ -- Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group) announce today that they have initiated the first-in-human clinical study of OBT357 (MEN1112), a novel enhanced antibody for the treatment of acute myeloid leukemia (AML). This is the first of five development programs between th...

Monday 24th November 2014

UCLA Researchers Identify Protein Key To The Development Of Blood Stem Cells

Provided by Peter Bracke, UCLA Understanding the self-replication mechanisms is critical for improving stem cell therapies for blood-related diseases and cancers Led by Dr. Hanna Mikkola, a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, UCLA scientists have discovered a protein that is integral to the self-replication of hematopoietic stem cells during...

Pathology specialist contributes to debate on breast cancer gene screening

(Women & Infants Hospital) What are the risks and benefits of screening for BRCA1 and BRCA2 mutations in the general adult population? Dr. Glenn Palomaki has published an invited commentary in Genetics in Medicine on this issue.

Cocrystal Pharma and RFS Pharma Merge to Create Advanced Antiviral Development Organization

BOTHELL, WA and ATLANTA, GA--(Marketwired - November 25, 2014) - Cocrystal Pharma, Inc. (OTCQB: COCP), a biotechnology company developing novel antiviral therapeutics for human diseases, today announced the closing of its merger with RFS Pharma, LLC, a privately owned biotech company founded by renowned drug developer, Dr. Raymond Schinazi. Since 2004, RFS Pharma has been working on the developmen...

Threshold Pharmaceuticals Announces Presentations and Webcasts at Upcoming Investor Meetings in December 2014

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/25/14 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present a company overview at the 26th Annual Piper Jaffray Healthcare Conference on December 2, 2014, at 11:30 a.m. Eastern Time and at the Oppenheimer 25th Annual Healthcare Conference on December 11, 2014, at ...

Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property

SAN DIEGO, CA -- (Marketwired) -- 11/25/14 -- Regen BioPharma Inc. (OTCBB: RGBP) announced today acquisition of patent application # US 13/652,395 with a priority date of November 2008 which covers a novel gene target essential for the survival of cancer stem cells. Inventors of the intellectual property on which this patent application was filed are University of Toronto Hematologist Dr. Richard...

Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property

SAN DIEGO, CA--(Marketwired - November 25, 2014) - Regen BioPharma Inc. (OTCBB: RGBP) announced today acquisition of patent application # US 13/652,395 with a priority date of November 2008 which covers a novel gene target essential for the survival of cancer stem cells. Inventors of the intellectual property...

Centipede's genome reveals how life evolved on our planet

(The Hebrew University of Jerusalem) Centipedes have been genetically sequenced for the first time by an international team of over 100 scientists. Study co-author Prof. Ariel Chipman at the Hebrew University of Jerusalem says the humble arthropod's...

Bioengineering study finds two-cell mouse embryos already talking about their future

(University of California - San Diego) Bioengineers at the University of California, San Diego have discovered that mouse embryos are contemplating their cellular fates in the earliest stages after fertilization when the embryo has only two to four c...

J&J, Transposagen partner to develop CAR T therapies

The Janssen unit of Johnson & Johnson (NYSE:JNJ) and Transposagen Biopharmaceuticals Inc. (Lexington, Ky.) have started a three-year research collaboration to develop allogeneic CAR T therapies using Transposagen's piggyBac Footprint-Free Gene Editin...

BioMarin to acquire Prosensa

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has concluded it can successfully make the case to gain approval for drisapersen to treat Duchenne muscular dystrophy after it acquires Prosensa Holding N.V. (NASDAQ:RNA) for $680 million in cash up front an...

P53: The Gene That Cracked the Cancer Code by Sue Armstrong – Review

(The Guardian) – As Sue Armstrong points out at the beginning of her book, while we may naively wonder why so many people get cancer, researchers are asking “Why so few?”. Every time a cell divides – skin and digestive-tract … Read ...

JAX research team identifies new mechanism for misfolded proteins in heart disease

A Jackson Laboratory research team has found that the misfolded proteins implicated in several cardiac diseases could be the result not of a mutated gene, but of mistranslations during the "editing" process of protein synthesis.read more

Peptic ulcer, cancer bacteria therapy discovery

Vegetable oil ingredient may provide cheap way to control infection billions have.

Functional optimization of gene clusters by combinatorial design and assembly

Combinatorial replacement and rearrangement of genetic parts in a refactored nitrogen fixation gene cluster lead to improved performance.


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks